QIAGEN showcases innovation in NGS solutions for precision medicine at ASCO 2018
● Introduces pipeline to reach patients more quickly with next-generation sequencing for cancer, in line with modernized regulatory approach from the U.S. Food and Drug Administration ● Announces partnership with Freenome to accelerate companion diagnostics development in immuno-oncology by combining industry-leading artificial intelligence with QIAGEN’s Sample to Insight solutions ● Showcases QIAGEN’s NGS technologies, including... Read more